Limitations
depression, anxiety
This study included 47 participants and followed clients over a 2-month period. The therapy sessions provided by the therapists in the TAU group were not captured by the AI platform, and therefore, it is impossible to assess whether these therapists used other decision-support tools to improve practice. The small sample size and the length of the study are important limitations of this trial, particularly compared to other studies involving AI or digital tools. To further clarify these results, we encourage future research to replicate this study with a larger sample size and a longer follow-up period. Of note, the study participants presented with baseline depression and anxiety symptoms that were mostly mild to moderate in severity. Thus, future research should explore the applicability and effectiveness of AI platforms in treating individuals with severe mental illnesses and symptoms. This trial also lacks detailed data on the patients’ experience in therapy, as their satisfaction was assessed by only 2 items. The validity of AI feedback as an adjunct to clinical supervision was outside the scope of this study; however, it should be tested in future research.